Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Bullish Jan. 21, 2022 Seeking Alpha article: https://seekingalpha.com/article/4480794-outlook-therapeutics-fda-approval-possible-buyout?mailingid=26453681&messageid=must_reads&serial=26453681.108183&utm_campaign=Must%2BRead%2BJanuary%2B22%2C%2B2022&utm_content=seeking_alpha&utm_medium=email&utm_source=seeking_alpha&utm_term=must_reads
Excellent point.
Spartex, I’m not saying one way is better than the other. Astute individuals with less risk aversion who’ve done their due diligence profit greatly from weighted investments, hopefully including those that bought NWBO at $5. It’s happened before with other biotech companies. That’s no less of a rational approach than one from a more conservative investor, but it’s definitely a riskier approach.
JMJJ, Just to add, risk is measured across a broad spectrum. For example, one could invest 50%, more than your 10%, of one's portfolio/assets in NWBO, and still prevent from being wiped out. Also, one's total net worth is likely part of the equation.
BO at $40 at some point would be great.
Sir P, your post gave me a shill.
GFTB, Thanks for all the OTLK MB posts. I've got many OTLK shares and down 35% as I bought right before the recent financings last year. I watched the HCW event this morning and liked what the CEO had to say. The trail was designed in coordination with the FDA, BLA submission to FDA this quarter, and a good chance of FDA approval before YE 2022. They also have a pipeline so the stock should go higher than the 12-month price target of $7-8 pps in '23 and beyond. It also sounds like they are going it alone vs. BO with mention of a sales force to launch revenues.
Stonk, not speaking for flipper of course, but just wanted to make sure you were aware that Refrad reported that DI implied it; DI did not state it as fact. Many well-informed posters here believe a rolling BLA has definitely been started and even close to completion.
Yeah, I sold my shares about a month ago, and took a small loss. After some additional dd, I decided it wasn't the right time to buy BLI. I think it's still a good long-term play for those willing to wait.
$7.00, but much higher later due to BO, partnership, or going it alone.
MB, I think you're right, and perhaps a much higher pps much later. I'm glad I'm only 60.
100%. That’s varsity politics.
Imagine if the pps had stayed in the $2 range up until the release of TLD. Nobody would be worried today. But if the trial fails, the pps will drop to pennies in minutes if not seconds. So, the point is that this pps movement prior to TLD is not relevant for most longs. Everything will be fine eventually.
I’m tempted to take up remote viewing :)
Based on 6 Wall Street analysts offering 12 month price targets for Berkeley Lights in the last 3 months. The average price target is $55.75 with a high forecast of $100.00 and a low forecast of $36.00. The average price target represents a 175.04% change from the last price of $20.27. https://www.tipranks.com/stocks/bli/forecast
The 5 analysts offering 12-month price forecasts for Berkeley Lights Inc have a median target of 45.00, with a high estimate of 100.00 and a low estimate of 36.00. The median estimate represents a +122.88% increase from the last price of 20.19.
https://money.cnn.com/quote/forecast/forecast.html?symb=BLI
Plenty of talk of her on the NWBO board. I'm long on NWBO.
Also, from December 1, 2021 - “The tech-heavy Nasdaq closed out Wednesday with a nosedive, rattled by a scary earnings outlook and the first confirmed U.S. case of the Covid-19 Omicron variant. The S&P 500 and the Dow Jones Industrial Average sank, too, worried about how badly Omicron could hurt America’s economy and what the Federal Reserve might—or might not—do to control the damage.” https://www.barrons.com/amp/articles/stock-market-today-51638356069
No wonder this morning's pre-market dropped to $1.22. Of course, I took out a giant position in OTLK about two weeks ago at $2.11. I didn't do enough due diligence, I suppose. Fortunately, I'm used to being patient and not panicking as I have an even larger stake in NWBO. It seems a buyout is less likely now, but better in the long-run for shareholders. TIA for any comments...
Funny, I just had a couple shots last weekend with my Kim-chee. Regarding NWBO, I had a million shares, then had to sell a quarter of them due to an unexpected emergency situation a couple months ago. I’m ready to buy 100,000 more once my deposit clears. It’s a tough wait, but we will get there eventually. Like your posts. GL.
Thanks to both Mavs. On CLPT’s website, Slide 13 of 28 of the Investor Presentation dated August 2021 states the Glioblastoma market opportunity at $2.4 billion in 2025 - 2026, much larger than all the other indications.
That reminds me of the old SNL Crossfire skit with Dan Aykroyd, “Jane, who’d you sleep with to get this job anyway.” :) Seriously bio, IMO your comments would read better without the insults.
Believe it people.
Is Pumpernickel drinking again? :)
ex, what is the significance of the four months in the “four-month note agreements”? tia
You took the words right out of my brain. Thx for the clear explanation anders.
If someone said, they had soup and salad yesterday, but in fact ate the salad first, I don’t think anyone would claim to be mislead. Stating items in a series could be based on timing, or priorities, or nothing at all. I think it’s a way to simply say they are waiting to release TLD until the publication is ready, which is consistent with what they’ve said all along.
That contract language is hard for me to understand.
Four months from June 30.
“You wanna make $14 the hard way?” :) Rodney Dangerfield at the top of his game.
Flipper, I’ll bet you $10.30 we have TLD or publication before 10/30. 10/30/2021, no tricks. I’m able to receive my winnings via PayPal.
I read it five times, and it says exactly that, TLD before October 30. I think this is clearer than the chronological assumption talked about earlier regarding publication preceding TLD. But unlike Poor Man, I’m unusually dense.
Sounds logical bio. I’d much rather deal with the silence than read about inane lawsuits related to pandering PR updates before TLD, conference, and publication.
Exactly.
LifeLock’s services aren’t cheap, but they are worth it for some. GL with everything.
Not that it matters, but remembering how we were stuck in the teens for so long, I’m content to wait in the $1.30s until the TLD PR and journal publication. However, my gut tells me we’ll return to $2.00 on no news in the interim.
My control number didn’t work for some reason. But since I’ve already vote, I successfully tested logging in as a guest.
I think a large sales team will be needed, one way or another.
That $9B and the $8B Merck had on-hand 4Q 2020 totaling $17B has a certain symmetry to it.
I remember that chemo peddler.